Newleos Doses First Patient in SOAR Phase 2 Anxiety Study
06 Jan 2026 //
BUSINESSWIRE
Newleos Therapeutics Names Timothy Noyes President, CEO
21 Oct 2025 //
PHARMIWEB
Newleos Pharma CEO Donabedian Honored By Goldman Sachs At 2025
15 Oct 2025 //
PHARMIWEB
Newleos Therapeutics Advances Neuropsychiatric Pipeline Progress
30 Sep 2025 //
BUSINESSWIRE
Newleos Posts 2025 Psychiatry Congress Data in Poster Session
09 Sep 2025 //
BUSINESSWIRE
Newleos Adds Stephen Brannan to Board, Updates on NTX-1955
23 Jul 2025 //
BUSINESSWIRE
Newleos Forms Clinical Advisory Board for Neuropsychiatry Program
29 Apr 2025 //
BUSINESSWIRE
Newleos Therapeutics Expands Leadership Team for Growth
08 Apr 2025 //
BUSINESSWIRE
Newleos Launches With $93.5M Series A To Neuropsychiatric Medicines
13 Feb 2025 //
BUSINESSWIRE

Market Place
Sourcing Support